Chuang Hao-Yuan
Chief Financial Officer
Chuang Hao-Yuan has filed 4 SEC Form 4 filings (26 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Sep 9, 2026.
On the most recent filing, Chuang Hao-Yuan is listed as Chief Financial Officer at BELITE BIO, INC. Inside the rolling window, Chuang Hao-Yuan reported no open-market purchases and 4 open-market sales totaling $14.0M in BLTE. The largest disclosed transaction in the window is a sale of 49,433 BLTE shares on Sep 4, 2026, worth $9.3M.
Companies traded
Other insiders at BLTE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$14.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Chuang Hao-Yuan made?
Chuang Hao-Yuan has filed 4 SEC Form 4 filings (26 transaction rows) across 1 company since 2026.
Which companies does Chuang Hao-Yuan trade?
Chuang Hao-Yuan has filed SEC Form 4 disclosures for 1 company, including BLTE.
When was Chuang Hao-Yuan's most recent SEC Form 4 filing?
Chuang Hao-Yuan's most recent SEC Form 4 filing on Tracefour is dated Sep 9, 2026.
What is Chuang Hao-Yuan's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Chuang Hao-Yuan is listed as Chief Financial Officer.
What is Chuang Hao-Yuan's total buy and sell value in the current window?
Inside the rolling retention window, Chuang Hao-Yuan bought $0 and sold $14.0M based on SEC Form 4 filings.
What was Chuang Hao-Yuan's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 49,433 BLTE shares on 2026-09-04, worth $9.3M, per SEC Form 4 filings.